Atlas Trials

Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy

Clinical trial NCT06173245 · COMPLETED

Trial details

NCT number
NCT06173245
Sponsor
Egyptian Biomedical Research Network
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Subfoveal Choroidal ThicknessIntravitrealRanibizumabVisual AcuityDiabetic Retinopathy
Start date
2021-02-01
Primary completion
2023-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.